Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic
- 1 June 2020
- journal article
- editorial
- Published by Elsevier in European Urology
- Vol. 77 (6) , 667-668
Abstract
No abstract availableKeywords
Funding Information
- Ferring
- Meso Scale Diagnostics
- Roche
- AstraZeneca
- Bristol-Myers Squibb
- Pfizer
This publication has 4 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- How will country-based mitigation measures influence the course of the COVID-19 epidemic?The Lancet, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020